Clinical Trials: Gastric Cancer

Fort Smith : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Jonesboro : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Beverly HIlls : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Beverly HIlls : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

Bakersfield : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Burbank : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Duarte : City of Hope Cancer Center

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Los Angeles : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Redlands : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

San Francisco : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

San Francisco : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Hamden : Medical Oncology & Hematology PC

FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer

New Haven : Yale University School of Medicine

FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer

Torrington : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Waterbury : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Jacksonville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Jacksonville : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Jacksonville : Mayo Clinic

Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia

Miramar : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Ormond Beach : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

View More »

Pembroke Pines : Memorial Cancer Institute

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Athens : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Atlanta : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Atlanta : Piedmont Hospital Research Institute

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Macon : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Marietta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

View More »

Valdosta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Post Falls : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Chicago : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Gurnee : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Maryville : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Skokie : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

South Bend : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Ames : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Cedar Rapids : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Westwood : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Wichita : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Alexandria : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

Baton Rouge : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Baton Rouge : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

New Orleans : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Shreveport : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Bethesda : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Bethesda : National Cancer Institute

Safety Study of MGAH22 in HER2-positive Carcinomas

Boston : Massachusetts General Hospital

CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer

Boston : Dana-Farber Cancer Institute

CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer

Boston : Dana-Farber Cancer Institute

Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin

Boston : Massachusetts General Hospital Cancer Center

Safety Study of MGA271 in Refractory Cancer

Boston : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

St Louis : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Billings : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Omaha : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Omaha : Nebraska Cancer Specialists, Methodist Estabrook Cancer Center

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Basking Ridge : Memoral Sloan Kettering Cancer Center

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

East Orange : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Albuquerque : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Albuquerque : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

Albuquerque : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Commack : Memorial Sloan-Kettering Cancer Center @ Suffolk

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Jamaica : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Jamaica : Queens Cancer Center of Queens Hospital

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

New Hyde Park : Long Island Jewish Medical Center

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

New York : Memorial Sloan-Kettering Cancer Center

Afatinib (BIBW 2992) in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer

View More »

New York : Memorial Sloan-Kettering Cancer Center

Evaluation of Respiratory Motion-Corrected Cone-Beam CT in Radiation Treatment of Thoracic and Abdominal Cancers

New York : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

New York : Memorial Sloan-Kettering Cancer Center 1275 York Avenue

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

New York : Weill Medical College of Cornell University

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Rockville Centre : Memorial Sloan-Kettering at Mercy Medical Center

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Sleepy Hollow : Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Cleveland : University Hospital of Cleveland

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Columbus : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Oklahoma City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Tulsa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Hershey : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

Philadelphia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Philadelphia : Hospital of the University of Pennsylvania/Abramson Cancer Center

Safety Study of MGA271 in Refractory Cancer

Pittsburgh : University of Pittsburgh Cancer Institute

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Rockledge : Fox Chase Cancer Center

An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors

West Reading : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Providence : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Charleston : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Charleston : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

Charleston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Charleston : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Chattanooga : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Chattanooga : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Germantown : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Knoxville : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Memphis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

View More »

Memphis : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Nashville : Sarah Cannon Research Institute

Safety Study of MGA271 in Refractory Cancer

Nashville : Sarah Cannon Research Institute

Safety Study of MGAH22 in HER2-positive Carcinomas

Dallas : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Houston : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

Corpus Christi : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Houston : UT MD Anderson Cancer Center

Chemoradiation-Induced Nausea and Emesis: Quality of Life

Temple : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Seattle : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Morgantown : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Milwaukee : Medical College of Wisconsin

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Rosario : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

Bahia Blanca : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Buenos Aires : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Ciudad Autonoma de Buenos Aires : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Ciudada Autonoma : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Cordoba : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Quilmes : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Rosario : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Rosario : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Rosario Santa Fe : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Santa Fe : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Tucuman : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Bankstown : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Bedford Park : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Coburg : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

East Melbourne : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Footscray : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

View More »

Frankston : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Hobart : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Kogarah : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Kurralta Park : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Liverpool : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Melbourne : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Parkville : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Perth : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Port Macquarie :

A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer

Southport : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

St. Leonards : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Wollongong : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Woodville : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Graz : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Linz : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Salzburg : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Steyr : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Wien : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Bruxelles : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Edegem : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Gent : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Liège : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

Bonheiden : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Brugge : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Brussels : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Brussels (anderlecht) : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Brussels (woluwe-st-lambert) : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Edegem : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Leuven : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Leuven : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Liege : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Sarajevo : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Porto Alegre : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Salvador : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

São Paulo : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

São Paulo : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

Barretos : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Belo Horizonte : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Belo Horizonte : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Brasilia : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Caxias do Sul : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Curitiba : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Fortaleza : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Gavea : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Goiania : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Ijui : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Itajai : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Lajeados : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Londrina : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Passo Fundo : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Porto Alegre : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Porto Alegre : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Ribeirao Preto : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Rio de Janeiro : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Salvador : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Santo Andre : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Sao Jose Rio Preto : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Sao Paulo : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Sao Paulo : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Sorocaba : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Gabrovo : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Pleven : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Varna : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Vratsa : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

Haskovo : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Pleven : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Sofia : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Varna : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Sherbrooke : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Concepcion : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

La Serena : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Providencia : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Santiago : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Vina del Mar : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Beijing : Beijing Cancer Hospital

Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis

Teusaquillo : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

Cali : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Monteria : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Osijek : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Zagreb : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

Osijek : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Pula : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Slavonski Brod : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Zagreb : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Brno : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Brno : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Hradec Kralove : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Liberec : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Olomouc : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

View More »

Pardubice : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Prague : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Praha 2 : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Pribram : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Alexandria : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Cairo : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Tallinn : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

Tallinn : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Besancon Cedex : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Clermont-Ferrand : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Marseille : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Montbeliard : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Montpellier : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

View More »

Paris : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Saint Etienne : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Aachen : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Essen : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Herne, NRW : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Leverkusen : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Muenchen : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Trier, RP : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

Berlin : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Bielefeld : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Bonn : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Dresden : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Essen : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Frankfurt : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Frankfurt :

A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer

Frankfurt :

An Observational Study of Herceptin (Trastuzumab) in Patients With HER2-positive Advanced Gastric Cancer

Frankfurt am Main : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Halle : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Hamburg : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Hamburg : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Heidelberg : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Leipzig : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Mainz : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Muenchen : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Recklinghausen : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Schweinfurt : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Tuebingen : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Ulm : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Guatemala City : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Hong Kong : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Budapest : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Gyor : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Nyíregyháza : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Pécs : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Szeged : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Székesfehérvár : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

Budapest : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Gyula : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Kaposvar : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Pecs : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Szekesfehervar : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Bangalore :

A Study of Herceptin (Trastuzumab) in Combination With Standard Chemotherapy in Patients With HER Positive Metastatic Gastric Cancer

Bangalore : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Chennai : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Chennai : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Chennai : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

View More »

Hyderabad : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Hyderabad : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Kolkata : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Kolkata : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Kolkata : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Mumbai : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Pune : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Pune : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Thiruvananthapuram : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

West Bengal : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Jakarta : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Sumatera Utara : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

West Java : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Beer Sheva : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Jerusalem : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Kfar Saba : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Ramat Gan : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Tel Aviv : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

Beer Sheva : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Haifa : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Holon : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Jerusalem : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Petah Tikva : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Tel Hashomer : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Milano : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Milano : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Modena : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Potenza : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Reggio Emilia : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Rimini : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

Ancona : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Ancona : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Aviano : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Bari : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Bergamo : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Brescia : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Catania : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Catanzaro :

A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer

Cremona : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Genova : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Lido di Camaiore : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Lucca : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Meldola : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Milano : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Milano : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Mirano : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Padova : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Pisa : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Pisa :

A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer

Pisa : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Potenza : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Rimini : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Torino : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Udine : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Bunkyo-ku : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Chiba : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Chikusa : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Chuo-ku : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Fukuoka : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

View More »

Hidaka : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Higashinari-Ku : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Kashiwa :

A Phase I Study of E7050 in Subjects With Solid Tumors

Kashiwa : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Kitaadachi-gun : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Kochi : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Matsuyama : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Mitaka : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Nagoya : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Osaka : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Osaka-Sayama : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Osaka-shi : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Sapporo : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Shimotsuke : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Sunto-gun : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Takatsuki : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Utsunomiya : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Yufu-shi : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Anyang : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Bundang City :

A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer

Daegu : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Incheon : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Jeonju : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

View More »

Seongnam : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Seongnam-si : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Seoul :

A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer

Seoul : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Seoul :

A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer

Seoul : Investigational Site Number 410001

Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy

Seoul : Administrative Office

Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer

Seoul : Seoul National University Hospital

Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapy

Seoul : Yonsei University Gangnam Severance Hospital

Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapy

Seoul : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Seoul : Seoul National University Hospital

Safety Study of MGAH22 in HER2-positive Carcinomas

Seoul : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Suwon : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Suwon-City : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Beirut : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Kaunas : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Klaipeda : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Kelantan : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Pulau Pinang : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Floriana : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Chihuahua : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

Aguascelientes : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Chihuahua : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Cuauhtemoc : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Juchitan : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Morelia : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Amsterdam : Nederlands Kanker Instituut/Antoni van Leeuwenhoek Ziekenhuis

Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS)

Cebu City : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Pasig City : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Gdansk : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Lodz : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Olsztyn : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Szczecin : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Warszawa : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

Brzozow : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Bydgoszcz : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Gdansk : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Krakow : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Lodz : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Lublin : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Olsztyn : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Poznan : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Warszawa : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Aveiro : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Coimbra : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Porto : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Baia Mare : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Cluj-Napoca : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Iasi : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Onesti : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

Baia Mare : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Bucuresti : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Cluj Napoca : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Iasi : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Suceava : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Targu Mures : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Barnaul : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Moscow : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Saint Petersburg : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Saint Petersburg : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Chelyabinsk : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Ivanovo : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Krasnodar : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Kursk : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Moscow : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

View More »

Moscow : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Perm : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Perm : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Pyatigorsk : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

St. Petersburg : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Ufa : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Singapore : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Durban : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Groenkloof Pretoria : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Port Elisabeth : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Pretoria : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Barcelona : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Barcelona : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Barcelona : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Barcelona : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Barcelona : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Elche : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Madrid : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Madrid : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Madrid : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Madrid : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Madrid : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Malaga : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Sabadell : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Valencia : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

A Coruna : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Avila : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Barcelona :

A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer

Barcelona : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Barcelona : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Burgos : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Córdoba :

A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer

Elche : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Jerez de la Frontera : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

La Coruna : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Madrid :

A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer

Madrid : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Madrid :

A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer

Madrid : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Madrid : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Majadahonda : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Malaga : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Oviedo :

A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer

Palma De Mallorca : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Sabadell : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Santander :

A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer

Santander : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Sevilla :

A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer

Sevilla : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Sevilla : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Toledo :

A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer

Changhua : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Kaohsiung : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Liouying/Tainan : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Taichung : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Taichung County : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

View More »

Tainan : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Taipei : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Taipei : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Taipei : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Bangkok : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Adana : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Gaziantep : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Istanbul : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Izmir : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Cherkassy : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Chernivtsiy : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Dnepropetrovsk : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Donetsk : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Kharkiv : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Kyiv : Research Site

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Lutsk : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Lviv : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Sumy : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Uzhgorod : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Zaporizzhya : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

London : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

Rhyl : Research Center

Diffuse Gastric and Esophagogastric junction cancer S-1 Trial

View More »

Aberdeen : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Bebington Wirral : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Guildford : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

London : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Maidstone : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Manchester : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Sutton : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Wolverhampton : Research Site

Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients

Wolverhampton : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma